Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Change in Cash (2020 - 2025)

Historic Change in Cash for Cellebrite DI (CLBT) over the last 6 years, with Q3 2025 value amounting to $102.3 million.

  • Cellebrite DI's Change in Cash rose 25887.84% to $102.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $144.1 million, marking a year-over-year increase of 776250.0%. This contributed to the annual value of $3.3 million for FY2024, which is 9669.34% down from last year.
  • As of Q3 2025, Cellebrite DI's Change in Cash stood at $102.3 million, which was up 25887.84% from $87.0 million recorded in Q2 2025.
  • In the past 5 years, Cellebrite DI's Change in Cash ranged from a high of $102.3 million in Q3 2025 and a low of -$102.0 million during Q1 2025
  • Over the past 5 years, Cellebrite DI's median Change in Cash value was $11.1 million (recorded in 2023), while the average stood at $7.8 million.
  • Its Change in Cash has fluctuated over the past 5 years, first surged by 1804049.3% in 2023, then crashed by 69670.62% in 2024.
  • Quarter analysis of 5 years shows Cellebrite DI's Change in Cash stood at $36.2 million in 2021, then crashed by 99.21% to $284000.0 in 2022, then skyrocketed by 18040.49% to $51.5 million in 2023, then rose by 10.15% to $56.7 million in 2024, then surged by 80.32% to $102.3 million in 2025.
  • Its last three reported values are $102.3 million in Q3 2025, $87.0 million for Q2 2025, and -$102.0 million during Q1 2025.